An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online asked whether a lab-made version of IGF-1 called IGF-1 LR3 would still turn off (suppress) your body’s own growth-hormone system. The question is basically: if you give this IGF-1 analog, does your brain get the signal to stop making growth hormone (GH) like it does when GH itself is given? IGF-1 is a natural protein your body makes mostly in the liver when GH tells it to. It helps cells grow and helps muscles and bones respond to GH. IGF-1 LR3 is a modified form built in a lab. The modification makes it longer-lasting in the blood and less likely to get grabbed by some binding proteins, so it can act more strongly and for longer than ordinary IGF-1. It is not the same as GH, but it mimics IGF-1 activity in tissues. The questioner’s understanding is grounded in how the GH system normally works: GH from the pituitary gland causes IGF-1 to rise, and then higher IGF-1 feeds back to the brain and pituitary to reduce further GH release. That feedback loop is well documented with ordinary IGF-1. What’s less clear — and what the snippet reflects — is whether IGF-1 LR3 produces the same feedback. There’s reason to expect some feedback because LR3 activates the same IGF-1 receptors that signal “enough growth activity.” But the LR3 modification also changes how the molecule circulates and how it interacts with binding proteins, so the exact strength and timing of feedback may differ from natural IGF-1. In short: biologically plausible, but details depend on dose, duration, and what studies (if any) have been done in humans. This matters because people sometimes use IGF-1 LR3 to try to build muscle or speed recovery. If it suppresses your natural GH production, that could change how your body regulates growth processes over time. For athletes, bodybuilders, or anyone considering such substances, knowing whether you’ll temporarily or persistently blunt your own GH production affects both expected benefits and long-term health planning. It also matters for medical monitoring: if your body reduces GH output, it might alter other hormones and metabolic effects. Important caveats: IGF-1 LR3 is a laboratory-modified peptide not approved for general medical use by major regulators, and many claims about it come from animal studies, small experiments, or anecdote. Giving IGF-1 or its analogs can cause side effects like low blood sugar (because IGF-1 can act like insulin), swelling, joint pain, and possibly increase risks tied to excessive growth signaling. Interfering with the GH/IGF-1 axis can also have unpredictable downstream effects. If you’re on hormone therapy or have conditions like diabetes, heart disease, or cancer risk, messing with these signals can be unsafe. Always rely on qualified medical advice and approved treatments rather than unregulated compounds. Bottom line: It’s reasonable to expect IGF-1 LR3 would produce some negative feedback on GH, but the exact extent and clinical consequences are uncertain and risky without proper studies and medical oversight.
Source: r/Peptides